List of Excipients in API alogliptin and pioglitazone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing alogliptin and pioglitazone
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Takeda Pharmaceuticals America Inc | OSENI | alogliptin and pioglitazone | 64764-121 | ALCOHOL | 2029-06-04 |
Takeda Pharmaceuticals America Inc | OSENI | alogliptin and pioglitazone | 64764-121 | BUTYL ALCOHOL | 2029-06-04 |
Takeda Pharmaceuticals America Inc | OSENI | alogliptin and pioglitazone | 64764-121 | CARNAUBA WAX | 2029-06-04 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for alogliptin and pioglitazone
Excipient focus: ALCOHOL
alogliptin and pioglitazone drug variants containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
alogliptin and pioglitazone drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
alogliptin and pioglitazone drug variants containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
alogliptin and pioglitazone drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
alogliptin and pioglitazone drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
alogliptin and pioglitazone drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
alogliptin and pioglitazone drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
alogliptin and pioglitazone drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
alogliptin and pioglitazone drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
alogliptin and pioglitazone drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
alogliptin and pioglitazone drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
alogliptin and pioglitazone drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
alogliptin and pioglitazone drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYGLYCERYL-10 OLEATE
alogliptin and pioglitazone drug variants containing POLYGLYCERYL-10 OLEATE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing POLYGLYCERYL-10 OLEATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
alogliptin and pioglitazone drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
alogliptin and pioglitazone drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
alogliptin and pioglitazone drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-121 |
Takeda Pharmaceuticals America Inc | alogliptin and pioglitazone | 64764-123 |
>Company | >Ingredient | >NDC |
alogliptin and pioglitazone drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.